Qube Research & Technologies (QRT)
FENC icon

Qube Research & Technologies (QRT)’s Fennec Pharmaceuticals FENC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Sell
29,378
-15,314
-34% -$118K ﹤0.01% 2978
2025
Q4 		$344K Buy
+44,692
New +$367K ﹤0.01% 2907
2025
Q1 		– Sell
-21,938
Closed -$139K – 3603
2024
Q4 		$139K Sell
21,938
-26,776
-55% -$137K ﹤0.01% 2921
2024
Q3 		$244K Buy
48,714
+1,730
+4% +$10K ﹤0.01% 2514
2024
Q2 		$287K Buy
46,984
+38,100
+429% +$316K ﹤0.01% 2324
2024
Q1 		$98.8K Buy
+8,884
New +$89.2K ﹤0.01% 3303
2023
Q2 		– Sell
-40,195
Closed -$334K – 2579
2023
Q1 		$334K Buy
40,195
+22,923
+133% +$213K ﹤0.01% 1708
2022
Q4 		$166K Buy
+17,272
New +$153K ﹤0.01% 1870

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Qube Research & Technologies (QRT)'s FENC Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Fennec Pharmaceuticals (FENC) stake by 34% in Q1 2026, selling an estimated $118K and leaving 29,378 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Qube Research & Technologies (QRT) first reported a position in FENC in Q4 2022 and has held it in 8 quarters since. The position peaked at $344K in Q4 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Qube Research & Technologies (QRT) held 29,378 shares of Fennec Pharmaceuticals worth $181K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 15,314 Fennec Pharmaceuticals shares in Q1 2026, an estimated $118K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2978 holding.
  • Qube Research & Technologies (QRT) first reported a position in Fennec Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Fennec Pharmaceuticals position peaked at $344K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.